Literature DB >> 21047511

Prediction of epitopes using neural network based methods.

Claus Lundegaard1, Ole Lund, Morten Nielsen.   

Abstract

In this paper, we describe the methodologies behind three different aspects of the NetMHC family for prediction of MHC class I binding, mainly to HLAs. We have updated the prediction servers, NetMHC-3.2, NetMHCpan-2.2, and a new consensus method, NetMHCcons, which, in their previous versions, have been evaluated to be among the very best performing MHC:peptide binding predictors available. Here we describe the background for these methods, and the rationale behind the different optimization steps implemented in the methods. We go through the practical use of the methods, which are publicly available in the form of relatively fast and simple web interfaces. Furthermore, we will review results obtained in actual epitope discovery projects where previous implementations of the described methods have been used in the initial selection of potential epitopes. Selected potential epitopes were all evaluated experimentally using ex vivo assays.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21047511      PMCID: PMC3134633          DOI: 10.1016/j.jim.2010.10.011

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  56 in total

Review 1.  Towards in silico prediction of immunogenic epitopes.

Authors:  Darren R Flower
Journal:  Trends Immunol       Date:  2003-12       Impact factor: 16.687

2.  Prediction of CTL epitopes using QM, SVM and ANN techniques.

Authors:  Manoj Bhasin; G P S Raghava
Journal:  Vaccine       Date:  2004-08-13       Impact factor: 3.641

Review 3.  Major histocompatibility complex class I binding predictions as a tool in epitope discovery.

Authors:  Claus Lundegaard; Ole Lund; Søren Buus; Morten Nielsen
Journal:  Immunology       Date:  2010-05-26       Impact factor: 7.397

Review 4.  Antigen processing is predictable: From genes to T cell epitopes.

Authors:  Stefan Stevanovic
Journal:  Transpl Immunol       Date:  2005-04-26       Impact factor: 1.708

5.  Peptide binding to HLA class I molecules: homogenous, high-throughput screening, and affinity assays.

Authors:  Mikkel Harndahl; Sune Justesen; Kasper Lamberth; Gustav Røder; Morten Nielsen; Søren Buus
Journal:  J Biomol Screen       Date:  2009-02-04

6.  Establishment of a quantitative ELISA capable of determining peptide - MHC class I interaction.

Authors:  C Sylvester-Hvid; N Kristensen; T Blicher; H Ferré; S L Lauemøller; X A Wolf; K Lamberth; M H Nissen; L Ø Pedersen; S Buus
Journal:  Tissue Antigens       Date:  2002-04

7.  MHC-I-restricted epitopes conserved among variola and other related orthopoxviruses are recognized by T cells 30 years after vaccination.

Authors:  S T Tang; M Wang; K Lamberth; M Harndahl; M H Dziegiel; M H Claesson; S Buus; O Lund
Journal:  Arch Virol       Date:  2008-09-12       Impact factor: 2.574

8.  NetMHCpan, a method for MHC class I binding prediction beyond humans.

Authors:  Ilka Hoof; Bjoern Peters; John Sidney; Lasse Eggers Pedersen; Alessandro Sette; Ole Lund; Søren Buus; Morten Nielsen
Journal:  Immunogenetics       Date:  2008-11-12       Impact factor: 2.846

9.  NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence.

Authors:  Morten Nielsen; Claus Lundegaard; Thomas Blicher; Kasper Lamberth; Mikkel Harndahl; Sune Justesen; Gustav Røder; Bjoern Peters; Alessandro Sette; Ole Lund; Søren Buus
Journal:  PLoS One       Date:  2007-08-29       Impact factor: 3.240

10.  NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11.

Authors:  Claus Lundegaard; Kasper Lamberth; Mikkel Harndahl; Søren Buus; Ole Lund; Morten Nielsen
Journal:  Nucleic Acids Res       Date:  2008-05-07       Impact factor: 16.971

View more
  49 in total

1.  Predictions versus high-throughput experiments in T-cell epitope discovery: competition or synergy?

Authors:  Claus Lundegaard; Ole Lund; Morten Nielsen
Journal:  Expert Rev Vaccines       Date:  2012-01       Impact factor: 5.217

2.  A combined prediction strategy increases identification of peptides bound with high affinity and stability to porcine MHC class I molecules SLA-1*04:01, SLA-2*04:01, and SLA-3*04:01.

Authors:  Lasse Eggers Pedersen; Michael Rasmussen; Mikkel Harndahl; Morten Nielsen; Søren Buus; Gregers Jungersen
Journal:  Immunogenetics       Date:  2015-11-14       Impact factor: 2.846

3.  Comparison of experimental fine-mapping to in silico prediction results of HIV-1 epitopes reveals ongoing need for mapping experiments.

Authors:  Julia Roider; Tim Meissner; Franziska Kraut; Thomas Vollbrecht; Renate Stirner; Johannes R Bogner; Rika Draenert
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

4.  In silico and cell-based analyses reveal strong divergence between prediction and observation of T-cell-recognized tumor antigen T-cell epitopes.

Authors:  Julien Schmidt; Philippe Guillaume; Danijel Dojcinovic; Julia Karbach; George Coukos; Immanuel Luescher
Journal:  J Biol Chem       Date:  2017-05-23       Impact factor: 5.157

5.  BlockLogo: visualization of peptide and sequence motif conservation.

Authors:  Lars Rønn Olsen; Ulrich Johan Kudahl; Christian Simon; Jing Sun; Christian Schönbach; Ellis L Reinherz; Guang Lan Zhang; Vladimir Brusic
Journal:  J Immunol Methods       Date:  2013-08-31       Impact factor: 2.303

6.  Getting personal with neoantigen-based therapeutic cancer vaccines.

Authors:  Nir Hacohen; Edward F Fritsch; Todd A Carter; Eric S Lander; Catherine J Wu
Journal:  Cancer Immunol Res       Date:  2013-04-07       Impact factor: 11.151

Review 7.  Neoantigen-based cancer immunotherapy.

Authors:  Sara Bobisse; Periklis G Foukas; George Coukos; Alexandre Harari
Journal:  Ann Transl Med       Date:  2016-07

Review 8.  Current tools for predicting cancer-specific T cell immunity.

Authors:  David Gfeller; Michal Bassani-Sternberg; Julien Schmidt; Immanuel F Luescher
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

9.  MULTIPRED2: a computational system for large-scale identification of peptides predicted to bind to HLA supertypes and alleles.

Authors:  Guang Lan Zhang; David S DeLuca; Derin B Keskin; Lou Chitkushev; Tanya Zlateva; Ole Lund; Ellis L Reinherz; Vladimir Brusic
Journal:  J Immunol Methods       Date:  2010-12-02       Impact factor: 2.303

Review 10.  Tumor neoantigens: building a framework for personalized cancer immunotherapy.

Authors:  Matthew M Gubin; Maxim N Artyomov; Elaine R Mardis; Robert D Schreiber
Journal:  J Clin Invest       Date:  2015-08-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.